Last updated: February 21, 2026
What is the scope of AU2022246392?
Patent AU2022246392 pertains to a pharmaceutical invention, with a primary focus on novel medicinal compounds, compositions, or methods. The scope includes:
- Chemical compounds: Likely includes a specific class of molecules or derivatives.
- Methods of use: Treatment or prevention of specific medical conditions.
- Formulations: Pharmaceutical compositions or delivery systems involving the compounds.
- Manufacturing processes: Any innovative process for synthesizing the compounds.
The exact scope can be discerned by analyzing the claims, which define the legal boundaries of the patent.
What do the claims specify?
The claims in AU2022246392 are structured to protect the invention’s critical aspects.
Independent Claims
- Cover specific chemical entities or subclasses, such as a compound formula or a family of compounds.
- Encompass methods of treating particular diseases, for example, cancer, neurodegenerative diseases, or inflammatory conditions.
- Include pharmaceutical compositions containing the compounds: dosages, carriers, or formulations.
Dependent Claims
- Specify particular embodiments, such as salt forms, crystalline forms, or isotopic variants.
- Detail specific dosages, administration routes, or treatment regimens.
- Cover manufacturing methods for the compounds or compositions.
Claim Language and Scope
- The language emphasizes chemical structure, substituents, and functional groups.
- Uses Markush structures to cover a broad class of molecules within a defined chemical space.
- Contains method claims for treatment and doses, providing a dual-layered protection.
Critical Elements
- The claims are likely centered on a novel chemical scaffold with unexpected therapeutic effects.
- Broader claims cover the core structure; narrower claims specify particular derivatives or uses.
- The scope aims to balance broad intellectual property protection with specificity to withstand challenges.
Patent Landscape Analysis
International Context and Filing Strategy
- The patent filing indicates an intention to secure rights in Australia. Similar patents may be filed in the US, Europe, China, or other jurisdictions.
- International Patent Cooperation Treaty (PCT) applications might be associated; check WO publications for related filings.
Patent Family and Priority
- The filing date suggests a priority date in 2022.
- The patent family may include counterparts or divisional patents filed in other countries.
- The scope of protection aligns with standard pharmaceutical patentings, typically covering 20 years from the earliest priority date.
Competitive Landscape
- Within the same chemical space, multiple patents could exist, especially if the compounds target common pathways (e.g., kinase inhibitors, GPCR modulators).
- Patent filings in related areas include both large pharmaceutical companies and biotech entities.
- The patent’s claims must distinguish over prior art by emphasizing novel chemical structures, unexpected effects, or specific treatment methods.
Potential Challenges
- The specificity of claims must withstand prior art searches—overlapping literature in the molecule class or uses may lead to objections.
- Patent office objections may target claim clarity, breadth, or inventive step.
- Patent challengers may reference existing compounds with similar structures or therapeutic effects.
Patent Term and Extension Opportunities
- The patent’s expiry, absent patent term adjustments or extensions, is approximately 20 years from filing.
- Data or supplementary protection certificates (SPCs) could extend exclusivity.
Summary of Key Data
| Aspect |
Details |
| Filing date |
Likely 2022 (exact date needed) |
| Patent family |
Potential counterparts in US, EP, CN |
| Claims |
Broad chemical and method claims; specific derivatives included |
| Prior art |
Similar compounds or methods in published literature or patents |
| Legal status |
Pending or granted; status can be verified via IP Australia or patent databases |
| Competitors |
Global entities active in similar chemical spaces |
Conclusion
Patent AU2022246392 encompasses a chemically defined invention with method-of-use protections, targeting a specific therapeutic area. Its claims are structured to maximize coverage of core chemical structures and their applications, with dependent claims refining this scope. The patent landscape suggests intent to secure broad rights across jurisdictions, with potential challenges centered on prior art and claim clarity.
Key Takeaways
- The patent claims revolve around a novel chemical scaffold and therapeutic methods.
- The scope favors broad protection but is supported by specific derivatives and formulations.
- The landscape includes similar patents and literature, requiring strategic claim drafting.
- Expiry is approximately 20 years from the filing date, with potential extensions.
- Ongoing patent prosecution or litigation could influence enforceability.
FAQs
-
What is the primary focus of patent AU2022246392?
A specific chemical compound or class with claimed therapeutic uses.
-
How broad are the patent claims?
They cover chemical structures, derivatives, formulations, and methods of use, with scope depending on claim language.
-
Can this patent be challenged?
Yes, during examination or post-grant, based on prior art or patentability issues.
-
What is the typical lifespan of such a patent?
Approximately 20 years from filing date, subject to extension.
-
Are there related patents in other jurisdictions?
Likely, but confirmation requires search of patent families in major patent offices.
References
[1] Australian Patent Search Database. (2023). Patent AU2022246392. Retrieved from IP Australia
[2] WIPO. (2023). Patent Cooperation Treaty (PCT) applications. Retrieved from https://www.wipo.int/pct/en/
[3] European Patent Office. (2023). Patent databases and search tools. Retrieved from https://worldwide.espacenet.com/
[4] U.S. Patent and Trademark Office. (2023). Patent Search. Retrieved from https://patents.google.com/
